Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10068600rdf:typepubmed:Citationlld:pubmed
pubmed-article:10068600lifeskim:mentionsumls-concept:C0014644lld:lifeskim
pubmed-article:10068600lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10068600lifeskim:mentionsumls-concept:C1518997lld:lifeskim
pubmed-article:10068600lifeskim:mentionsumls-concept:C0149678lld:lifeskim
pubmed-article:10068600lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:10068600lifeskim:mentionsumls-concept:C2346689lld:lifeskim
pubmed-article:10068600lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:10068600lifeskim:mentionsumls-concept:C1550025lld:lifeskim
pubmed-article:10068600pubmed:issue4lld:pubmed
pubmed-article:10068600pubmed:dateCreated1999-4-21lld:pubmed
pubmed-article:10068600pubmed:abstractTextChronic active Epstein-Barr virus infection (CAEBV) is a severe illness with unusual EBV activation that persists for years, and its pathogenesis is largely unknown. After the creation of an accurate and reproducible polymerase chain reaction system to quantify EBV DNA, virus loads in peripheral blood lymphocytes (PBL) were determined in 54 children: 15 with CAEBV, 16 with infectious mononucleosis (IM), and 23 healthy children. Children with CAEBV and those with IM had high virus loads. Lower loads were detected in 47% of seropositive healthy donors. There were two distinct differences between children with CAEBV and those with IM: The former had greater viral replication (10(3)-10(7) copies/2.5x10(5) PBL) than those with IM, and viral replication declined in children with IM whereas active replication persisted for years in subjects with CAEBV. Persisting high virus loads are a possible diagnostic criterion for CAEBV. EBV loads may enable classification and prognosis of EBV infections.lld:pubmed
pubmed-article:10068600pubmed:languageenglld:pubmed
pubmed-article:10068600pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10068600pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10068600pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10068600pubmed:statusMEDLINElld:pubmed
pubmed-article:10068600pubmed:monthAprlld:pubmed
pubmed-article:10068600pubmed:issn0022-1899lld:pubmed
pubmed-article:10068600pubmed:authorpubmed-author:MaedaAAlld:pubmed
pubmed-article:10068600pubmed:authorpubmed-author:TomodaTTlld:pubmed
pubmed-article:10068600pubmed:authorpubmed-author:KurashigeTTlld:pubmed
pubmed-article:10068600pubmed:authorpubmed-author:WakiguchiHHlld:pubmed
pubmed-article:10068600pubmed:authorpubmed-author:HisakawaHHlld:pubmed
pubmed-article:10068600pubmed:authorpubmed-author:YokoyamaWWlld:pubmed
pubmed-article:10068600pubmed:issnTypePrintlld:pubmed
pubmed-article:10068600pubmed:volume179lld:pubmed
pubmed-article:10068600pubmed:ownerNLMlld:pubmed
pubmed-article:10068600pubmed:authorsCompleteYlld:pubmed
pubmed-article:10068600pubmed:pagination1012-5lld:pubmed
pubmed-article:10068600pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:meshHeadingpubmed-meshheading:10068600...lld:pubmed
pubmed-article:10068600pubmed:year1999lld:pubmed
pubmed-article:10068600pubmed:articleTitlePersistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection.lld:pubmed
pubmed-article:10068600pubmed:affiliationMicrobiology and Tumorbiology Center (MTC), Karolinska Institute, S-171 77, Stockholm, Sweden. akihiko.maeda@mtc.ki.selld:pubmed
pubmed-article:10068600pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10068600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10068600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10068600lld:pubmed